158 related articles for article (PubMed ID: 27328684)
1. Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.
Kimura M; Go M; Iwai M; Usami E; Teramachi H; Yoshimura T
J Oncol Pharm Pract; 2017 Sep; 23(6):413-421. PubMed ID: 27328684
[TBL] [Abstract][Full Text] [Related]
2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer.
Kimura M; Go M; Iwai M; Usami E; Teramachi H; Yoshimura T
Mol Clin Oncol; 2017 Sep; 7(3):486-492. PubMed ID: 28781821
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional Census Survey of Patients With Cancer who Received a Pharmacist Consultation in a Pharmacist Led Anti-cancer Clinic.
Dennis M; Haines A; Johnson M; Soggee J; Tong S; Parsons R; Sunderland B; Czarniak P
J Cancer Educ; 2022 Oct; 37(5):1553-1561. PubMed ID: 35867307
[TBL] [Abstract][Full Text] [Related]
5. [A Questionnaire Survey on Cooperation between Community Pharmacies and Hospitals in Outpatient Chemotherapy-Comparison of Roles of Pharmacists in Community Pharmacy and Hospitals].
Ishibashi M; Ishii M; Nagano M; Kiuchi Y; Iwamoto S
Yakugaku Zasshi; 2018; 138(3):425-435. PubMed ID: 29503434
[TBL] [Abstract][Full Text] [Related]
6. [Medical Assistance Based on Interviews Conducted before Physician Examination by a Pharmacist for Outpatients with Thyroid Cancer Treated with Lenvatinib].
Kawachi Y; Kimura M; Go M; Ohnishi M; Yoshimura T
Gan To Kagaku Ryoho; 2017 Jun; 44(6):507-511. PubMed ID: 28698443
[TBL] [Abstract][Full Text] [Related]
7. [Examination of the usefulness of the pharmacists' outpatient clinic for treatment with oral molecule-targeting drugs].
Aimono Y; Nemoto M; Sato W; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
Gan To Kagaku Ryoho; 2013 Jul; 40(7):901-5. PubMed ID: 23863732
[TBL] [Abstract][Full Text] [Related]
8. Assessment of patient perceptions of counselling on oral antineoplastic agents by a dedicated cancer services pharmacist in an outpatient cancer clinic.
McNabb L; Metrot E; Ferrington M; Sunderland B; Parsons R; Copeland TS; Corscadden S; Tong S; Czarniak P
PLoS One; 2024; 19(6):e0304011. PubMed ID: 38870231
[TBL] [Abstract][Full Text] [Related]
9. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ
Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274
[TBL] [Abstract][Full Text] [Related]
10. [Sharing Patient Safety Management Skills in Oncology Pharmaceutical Outpatient Service].
Kawakami K
Yakugaku Zasshi; 2023; 143(3):217-221. PubMed ID: 36858551
[TBL] [Abstract][Full Text] [Related]
11. Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients.
Tanaka K; Tachi T; Hori A; Osawa T; Nagaya K; Makino T; Inoue S; Yasuda M; Mizui T; Nakada T; Goto C; Teramachi H
Pharmazie; 2019 Jul; 74(7):439-442. PubMed ID: 31288902
[TBL] [Abstract][Full Text] [Related]
12. The effects of pharmacist interventions on adult outpatients with cancer: A systematic review.
Colombo LRP; Aguiar PM; Lima TM; Storpirtis S
J Clin Pharm Ther; 2017 Aug; 42(4):414-424. PubMed ID: 28556392
[TBL] [Abstract][Full Text] [Related]
13. Adherence to oral chemotherapy: Challenges and opportunities.
Krikorian S; Pories S; Tataronis G; Caughey T; Chervinsky K; Lotz M; Shen AH; Weissmann L
J Oncol Pharm Pract; 2019 Oct; 25(7):1590-1598. PubMed ID: 30253725
[TBL] [Abstract][Full Text] [Related]
14. Adherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient setting.
Kimura M; Nakashima K; Usami E; Iwai M; Nakao T; Yoshimura T; Mori H; Teramachi H
Oncol Lett; 2015 May; 9(5):2341-2346. PubMed ID: 26137068
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
16. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy.
Suzuki S; Chan A; Nomura H; Johnson PE; Endo K; Saito S
J Oncol Pharm Pract; 2017 Jan; 23(1):18-25. PubMed ID: 26561587
[TBL] [Abstract][Full Text] [Related]
18. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
Kalista T; Lemay V; Cohen L
J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
[TBL] [Abstract][Full Text] [Related]
19. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
20. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]